nach oben

European Archives of Oto-Rhino-Laryngology

Erschienen in:

Open Access 01.08.2008 | Review Article

Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis

verfasst von: Ferdinand I. Broekema, Frederik G. Dikkers

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 8/2008

Einloggen, um Zugang zu erhalten

Abstract

Recurrent respiratory papillomatosis (RRP) is a chronic and difficult to treat disease of the larynx. In 1998, the first article was published that described the use of the antiviral substance cidofovir to treat this disease. Although the results are promising, there remains some concern about the potential carcinogenicity of cidofovir. There is a demand for a qualitative review of the side-effects of this medicine. In this review, the side-effects of cidofovir are investigated. Special attention was given to the potential carcinogenicity of cidofovir. For this review a search is performed in PubMed and EMBASE for relevant articles in which the use of intralesional cidofovir for patients with RRP is described. Eventually, 31 articles could be included for this review. In these articles a total of 188 patients with RRP were described who underwent therapy with intralesional cidofovir. Five of these patients have developed dysplasia of the larynx during the treatment with cidofovir. This is a percentage of 2.7. This percentage is concurrent with the incidence of spontaneous malignant degeneration of RRP (2–3%). Based on this review, it can be concluded that the use of intralesional cidofovir does not increase the risk of laryngeal dysplasia. Apart from the articles that describe the intralesional administration of cidofovir, some articles have been published in which the use of intravenous cidofovir is described as a therapy for RRP. Therefore, a summary is given on the side-effects of intralesional cidofovir as well as a summary on the reported side-effects of the intravenous administration of cidofovir. Based on the outcomes of this review, recommendations are given for a safe use of cidofovir for treatment of recurrent respiratory papillomatosis in the future.

Akst LM, Lee W, Discolo C, Knott D, Younes A, Koltai PJ (2003) Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg 129:841–846CrossRefPubMed

Armbruster C, Kreuzer A, Vorbach H, Huber M, Armbruster C (2001) Successful treatment of severe respiratory papillomatosis with intravenous cidofovir and interferon alpha-2b. Eur Respir J 17:830–831CrossRefPubMed

Askew J, Black R (2005) Intralesional cidofovir use in recurrent respiratory papillomatosis of childhood. Aust J Otolaryng 8:26–29

Avelino M, Gutzman R, Fujita R, Pignatari S, Weckx L, Pontes P (2004) Cidofovir effects on recurrent laryngeal papillomatosis in children: preliminary report. Rev Bras Otorrinolaringol 70:734–738CrossRef

Bauman NM, Smith RJ (1996) Recurrent respiratory papillomatosis. Pediatr Clin North Am 43:1385–1401CrossRefPubMed

Bielamowicz S, Villagomez V, Stager SV, Wilson WR (2002) Intralesional cidofovir therapy for laryngeal papilloma in an adult cohort. Laryngoscope 112:696–699CrossRefPubMed

Bila V, Otova B, Jelinek R, Sladka M, Mejsnarova B, Holy A, Kren V (1993) Antimitotic and teratogenic effects of acyclic nucleotide analogues 1-(S)-(3-hydroxy-2-phosphonomethoxyethyl)cytosine (HPMPC) and 9-(2-phosphonomethoxyethyl) adenine (PMEA). Folia Biol (Praha) 39:150–161

Byrne JC, Tsao MS, Fraser RS, Howley PM (1987) Human papillomavirus-11 DNA in a patient with chronic laryngotracheobronchial papillomatosis and metastatic squamous-cell carcinoma of the lung. N Engl J Med 317:873–878PubMed

Chhetri DK, Blumin JH, Shapiro NL, Berke GS (2002) Office-based treatment of laryngeal papillomatosis with percutaneous injection of cidofovir. Otolaryngol Head Neck Surg 126:642–648CrossRefPubMed

10.

Chhetri DK, Jahan-Parwar B, Hart SD, Bhuta SM, Berke GS, Shapiro NL (2003) Local and systemic effects of intralaryngeal injection of cidofovir in a canine model. Laryngoscope 113:1922–1926CrossRefPubMed

11.

Chhetri DK, Shapiro NL (2003) A scheduled protocol for the treatment of juvenile recurrent respiratory papillomatosis with intralesional cidofovir. Arch Otolaryngol Head Neck Surg 129:1081–1085CrossRefPubMed

12.

Chung BJ, Akst LM, Koltai PJ (2006) 3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 70:1911–1917PubMed

13.

Co J, Woo P (2004) Serial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 113:859–862PubMed

14.

Coulombeau B, Nusa NA, Ceruse P, Froehlich P (2002) [Anti-viral injectable treatment (cidofovir) in laryngeal papillomatosis]. Rev Laryngol Otol Rhinol (Bord) 123:315–320

15.

Cundy KC (1999) Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin Pharmacokinet 36:127–143CrossRefPubMed

16.

Dallimore NS (1985) Squamous bronchial carcinoma arising in a case of multiple juvenile papillomatosis. Thorax 40:797–798PubMedCrossRef

17.

Dancey DR, Chamberlain DW, Krajden M, Palefsky J, Alberti PW, Downey GP (2000) Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature. Chest 118:1210–1214CrossRefPubMed

18.

de Bilderling G, Bodart E, Lawson G, Tuerlinckx D, Remacle M, Naesens L, De Clercq E, Snoeck R (2005) Successful use of intralesional and intravenous cidofovir in association with indole-3-carbinol in an 8-year-old girl with pulmonary papillomatosis. J Med Virol 75:332–335CrossRefPubMed

19.

Derkay C (2005) Cidofovir for recurrent respiratory papillomatosis (RRP): a re-assessment of risks. Int J Pediatr Otorhinolaryngol 69:1465–1467CrossRefPubMed

20.

Dikkers FG (2006) Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir-a prospective study. Eur Arch Otorhinolaryngol 263:440–443CrossRefPubMed

21.

El Aatmani M, Steinmetz A, Debry D, Levêque D, Koffel J-C, Beretz L (2002) À propos d’un cas de traitement de la papillomatose laryngée récidivante par injections intralésionnelles de cidofovir (Vistide). J Pharm Clin 21:287–290

22.

El Hakim H, Waddell AN, Crysdale WS (2002) Observations on the early results of treatment of recurrent respiratory papillomatosis using cidofovir. J Otolaryngol 31:333–335CrossRefPubMed

23.

Food and Drug Administration. http://www.fda.gov/cder/handbook/categc.htm

24.

Food and Drug Administration. 1996 http://www.fda.gov/cder/foi/adcomm/96/avdac_joint_031496_summmin_ac.pdf

25.

Gilead Sciences. Inc. 2000 Vistide (cidofovir) package insert. Foster City, CA

26.

Giles BL, Seifert B (2006) CR12/339–Nebulized cidofovir for recurrent respiratory papillomatosis: a case report. Paediatr Respir Rev 7(Suppl 1):S330PubMed

27.

Guillou L, Sahli R, Chaubert P, Monnier P, Cuttat JF, Costa J (1991) Squamous cell carcinoma of the lung in a nonsmoking, nonirradiated patient with juvenile laryngotracheal papillomatosis. Evidence of human papillomavirus-11 DNA in both carcinoma and papillomas. Am J Surg Pathol 15:891–898PubMedCrossRef

28.

Hoffman VF, Skiest DJ (2000) Therapeutic developments in cytomegalovirus retinitis. Expert Opin Investig Drugs 9:207–220CrossRefPubMed

29.

Kimberlin DW (2004) Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosis. Antiviral Res 63:141–151PubMed

30.

Lee AS, Rosen CA (2004) Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis. J Voice 18:551–556CrossRefPubMed

31.

Lindeberg H, Syrjanen S, Karja J, Syrjanen K (1989) Human papillomavirus type 11 DNA in squamous cell carcinomas and pre-existing multiple laryngeal papillomas. Acta Otolaryngol 107:141–149CrossRefPubMed

32.

Mandell DL, Arjmand EM, Kay DJ, Casselbrant ML, Rosen CA (2004) Intralesional cidofovir for pediatric recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 130:1319–1323CrossRefPubMed

33.

Milczuk HA (2003) Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children. Otolaryngol Head Neck Surg 128:788–794CrossRefPubMed

34.

Moore CE, Wiatrak BJ, McClatchey KD, Koopmann CF, Thomas GR, Bradford CR, Carey TE (1999) High-risk human papillomavirus types and squamous cell carcinoma in patients with respiratory papillomas. Otolaryngol Head Neck Surg 120:698–705CrossRefPubMed

35.

Naiman AN, Abedipour D, Ayari S, Fresnel E, Coulombeau B, Bour JB, Froehlich P (2006) Natural history of adult-onset laryngeal papillomatosis following multiple cidofovir injections. Ann Otol Rhinol Laryngol 115:175–181PubMed

36.

Naiman AN, Ayari S, Nicollas R, Landry G, Coulombeau B, Froehlich P (2006) Intermediate-term and long-term results after treatment by cidofovir and excision in juvenile laryngeal papillomatosis. Ann Otol Rhinol Laryngol 115:667–672PubMed

37.

Naiman AN, Ceruse P, Coulombeau B, Froehlich P (2003) Intralesional cidofovir and surgical excision for laryngeal papillomatosis. Laryngoscope 113:2174–2181CrossRefPubMed

38.

Naiman AN, Roger G, Gagnieu MC, Bordenave J, Mathaut S, Ayari S, Nicollas R, Bour JB, Garabedian N, Froehlich P (2004) Cidofovir plasma assays after local injection in respiratory papillomatosis. Laryngoscope 114:1151–1156CrossRefPubMed

39.

Neumann K, Pudszuhn A, Welzel C, Bartel-Friedrich S, Passmann M (2003) [Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results]. Laryngorhinootologie 82:700–706CrossRefPubMed

40.

Palomar AV, Palomar GV, Soteras OJ, Ruiz GA (2005) [Cidofovir activity in infantile recurrent respiratory papillomatosis]. Acta Otorrinolaringol Esp 56:22–24

41.

Petersen BL, Buchwald C, Gerstoft J, Bretlau P, Lindeberg H (1998) An aggressive and invasive growth of juvenile papillomas involving the total respiratory tract. J Laryngol Otol 112:1101–1104CrossRefPubMed

42.

Peyton SW, Wiatrak B (2004) Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children? Int J Pediatr Otorhinolaryngol 68:413–418CrossRef

43.

Pontes P, Avelino M, Pignatari S, Weckx LL (2006) Effect of local application of cidofovir on the control of recurrences in recurrent laryngeal papillomatosis. Otolaryngol Head Neck Surg 135:22–27CrossRefPubMed

44.

Pou AM, Rimell FL, Jordan JA, Shoemaker DL, Johnson JT, Barua P, Post JC, Ehrlich GD (1995) Adult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis. Ann Otol Rhinol Laryngol 104:758–762PubMed

45.

Pransky SM, Albright JT, Magit AE (2003) Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir. Laryngoscope 113:1583–1587CrossRefPubMed

46.

Pransky SM, Brewster DF, Magit AE, Kearns DB (2000) Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 126:1239–1243PubMed

47.

Pransky SM, Magit AE, Kearns DB, Kang DR, Duncan NO (1999) Intralesional cidofovir for recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg 125:1143–1148PubMed

48.

Pudszuhn A, Welzel C, Bloching M, Neumann K (2007) Intralesional Cidofovir application in recurrent laryngeal papillomatosis. Eur Arch Otorhinolaryngol 264:63–70CrossRefPubMed

49.

Rady PL, Schnadig VJ, Weiss RL, Hughes TK, Tyring SK (1998) Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53. Laryngoscope 108:735–740CrossRefPubMed

50.

Sheahan P, Sexton S, Russell JD (2006) Is intralesional cidofovir worthwhile in juvenile recurrent respiratory papillomatosis? J Laryngol Otol 120:561–565CrossRefPubMed

51.

Snoeck R, Wellens W, Desloovere C, Van Ranst M, Naesens L, De Clercq E, Feenstra L (1998) Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]. J Med Virol 54:219–225CrossRefPubMed

52.

Spiegel JH, Andrus JG, Stefanato CM, Heeren T (2005) Histopathologic effects of cidofovir on cartilage. Otolaryngol Head Neck Surg 133:666–671CrossRefPubMed

53.

Van Valckenborgh I, Wellens W, De Boeck K, Snoeck R, De Clercq E, Feenstra L (2001) Systemic cidofovir in papillomatosis. Clin Infect Dis 32:E62–E64CrossRefPubMed

54.

Wachsman M, Petty BG, Cundy KC, Jaffe HS, Fisher PE, Pastelak A, Lietman PS (1996) Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects. Antiviral Res 29:153–161CrossRefPubMed

55.

Wemer RD, Lee JH, Hoffman HT, Robinson RA, Smith RJ (2005) Case of progressive dysplasia concomitant with intralesional cidofovir administration for recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 114:836–839PubMed

56.

Wilson WR, Hashemiyoon R, Hawrych A (2000) Intralesional cidofovir for recurrent laryngeal papillomas: preliminary report. Ear Nose Throat J 79:236–238, 240PubMed

Titel: Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis
verfasst von: Ferdinand I. Broekema
Frederik G. Dikkers
Publikationsdatum: 01.08.2008
Verlag: Springer-Verlag
Erschienen in: European Archives of Oto-Rhino-Laryngology / Ausgabe 8/2008
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-008-0658-0

Neu im Fachgebiet HNO

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis

Abstract

Neu im Fachgebiet HNO

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Eingreifen von Umstehenden rettet vor Erstickungstod

Real-World-Daten sprechen eher für Dupilumab als für Op.

Schwindelursache: Massagepistole lässt Otholiten tanzen

Update HNO

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2008

Surgical treatment of the high jugular bulb by compressing sinus sigmoideus: two cases

The future of European Archives of Oto-Rhino-Laryngology and Head & Neck

E-cadherin but not β-catenin expression is decreased in laryngeal biopsies from patients with laryngopharyngeal reflux

The European Academy of Otorhinolaryngology, Head & Neck Surgery (EAORL-HNS) and its affiliated members

Informed consent to satisfy everyone

The use of forced ventilation during microlaryngoscopy with laser CO2

Neu im Fachgebiet HNO

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Eingreifen von Umstehenden rettet vor Erstickungstod

Real-World-Daten sprechen eher für Dupilumab als für Op.

Schwindelursache: Massagepistole lässt Otholiten tanzen

Update HNO